Patents by Inventor Nadia Passini

Nadia Passini has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • THERAPEUTIC TREM-1 PEPTIDES
    Publication number: 20200254058
    Abstract: A polypeptide comprising one or more sequences derived from CDR2 or CDR3 of a TREM-1 protein, characterised by the ability to treat, ameliorate, or lessen the symptoms of conditions including sepsis, septic shock or sepsis-like conditions and IBD.
    Type: Application
    Filed: February 18, 2020
    Publication date: August 13, 2020
    Inventors: Gilbert FAURE, Sebastien GIBOT, Paola PANINA, Nadia PASSINI
  • Therapeutic TREM-1 peptides
    Patent number: 10603357
    Abstract: A polypeptide comprising one or more sequences derived from CDR2 or CDR3 of a TREM-1 protein, characterised by the ability to treat, ameliorate, or lessen the symptoms of conditions including sepsis, septic shock or sepsis-like conditions and IBD.
    Type: Grant
    Filed: December 14, 2015
    Date of Patent: March 31, 2020
    Assignees: Bristol-Myers Squibb Company, Universite de Lorraine
    Inventors: Gilbert Faure, Sebastien Gibot, Paola Panina, Nadia Passini
  • THERAPEUTIC TREM-1 PEPTIDES
    Publication number: 20160193288
    Abstract: A polypeptide comprising one or more sequences derived from CDR2 or CDR3 of a TREM-1 protein, characterised by the ability to treat, ameliorate, or lessen the symptoms of conditions including sepsis, septic shock or sepsis-like conditions and IBD.
    Type: Application
    Filed: December 14, 2015
    Publication date: July 7, 2016
    Inventors: Gilbert FAURE, Sebastien GIBOT, Paola PANINA, Nadia PASSINI
  • Therapeutic TREM-1 peptides
    Patent number: 9273111
    Abstract: A polypeptide comprising one or more sequences derived from CDR2 or CDR3 of a TREM-1 protein, characterized by the ability to treat, ameliorate, or lessen the symptoms of conditions including sepsis, septic shock or sepsis-like conditions and IBD.
    Type: Grant
    Filed: July 12, 2011
    Date of Patent: March 1, 2016
    Assignees: Universite de Lorraine, Bristol-Myers Squibb
    Inventors: Gilbert Faure, Sebastien Gibot, Paola Panina, Nadia Passini
  • TREATMENT OF CONDITIONS BY TOLL-LIKE RECEPTOR MODULATORS
    Publication number: 20120083473
    Abstract: Provided herein are methods for treating certain conditions, including fibrosis, inflammatory, and autoimmune conditions, with conjugated compounds having Toll-like receptor modulatory activity.
    Type: Application
    Filed: September 20, 2011
    Publication date: April 5, 2012
    Inventors: Johanna Holldack, Alberto Mantovani, Antonio Sica, Nadia Passini, Roberto Maj, Alcide Barberis
  • THERAPEUTIC PEPTIDES AND METHOD
    Publication number: 20120015867
    Abstract: A polypeptide comprising one or more sequences derived from CDR2 or CDR3 of a TREM-1 protein, characterised by the ability to treat, ameliorate, or lessen the symptoms of conditions including sepsis, septic shock or sepsis-like conditions and IBD.
    Type: Application
    Filed: July 12, 2011
    Publication date: January 19, 2012
    Inventors: Gilbert FAURE, Sebastien Gibot, Paola Panina, Nadia Passini
  • Therapeutic peptides and method
    Patent number: 8013116
    Abstract: A polypeptide comprising one or more sequences derived from CDR2 or CDR3 of a TREM-1 protein, characterized by the ability to treat, ameliorate, or lessen the symptoms of conditions including sepsis, septic shock or sepsis-like conditions and IBD.
    Type: Grant
    Filed: February 2, 2009
    Date of Patent: September 6, 2011
    Assignees: Universite Henri-Poincare-Nancy I, Novo Nordisk A/S
    Inventors: Gilbert Faure, Sebastien Gibot, Paola Panina, Nadia Passini
  • Therapeutic peptides and method
    Publication number: 20090253632
    Abstract: A polypeptide comprising one or more sequences derived from CDR2 or CDR3 of a TREM-1 protein, characterised by the ability to treat, ameliorate, or lessen the symptoms of conditions including sepsis, septic shock or sepsis-like conditions and IBD.
    Type: Application
    Filed: February 2, 2009
    Publication date: October 8, 2009
    Inventors: Gilbert Faure, Sebastien Gibot, Paola Panina, Nadia Passini
  • Therapeutic peptides and method
    Publication number: 20060246082
    Abstract: A polypeptide comprising one or more sequences derived from CDR2 or CDR3 of a TREM-1 protein, characterised by the ability to treat, ameliorate, or lessen the symptoms of sepsis, septic shock or sepsis-like conditions.
    Type: Application
    Filed: November 22, 2005
    Publication date: November 2, 2006
    Inventors: Gilbert Faure, Sebastien Gibot, Paola Panina, Nadia Passini